vs
OMNICELL, INC.(OMCL)与UiPath, Inc.(PATH)财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是OMNICELL, INC.的1.3倍($411.1M vs $309.9M),UiPath, Inc.净利率更高(48.4% vs 3.7%,领先44.7%),UiPath, Inc.同比增速更快(15.9% vs 14.9%),OMNICELL, INC.自由现金流更多($38.6M vs $25.1M),过去两年OMNICELL, INC.的营收复合增速更高(5.8% vs 0.7%)
Omnicell是总部位于美国加州山景城的跨国医疗科技企业,专注于为医院及各类医疗机构提供药品管理自动化系统,同时面向零售药房推出用药依从性包装与患者互动软件,旗下产品使用Omnicell及EnlivenHealth两大品牌。
UiPath是一家全球化软件企业,专注于开发人工智能、智能自动化及流程编排类软件,其产品支持用户搭建与调度AI代理,实现复杂业务流程、工作流的自动化运行,助力各行业客户提升运营效率、降低人力成本。
OMCL vs PATH — 直观对比
营收规模更大
PATH
是对方的1.3倍
$309.9M
营收增速更快
PATH
高出1.0%
14.9%
净利率更高
PATH
高出44.7%
3.7%
自由现金流更多
OMCL
多$13.5M
$25.1M
两年增速更快
OMCL
近两年复合增速
0.7%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $309.9M | $411.1M |
| 净利润 | $11.4M | $198.8M |
| 毛利率 | 45.3% | 83.3% |
| 营业利润率 | 60.1% | 3.2% |
| 净利率 | 3.7% | 48.4% |
| 营收同比 | 14.9% | 15.9% |
| 净利润同比 | — | 1966.2% |
| 每股收益(稀释后) | $0.25 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
OMCL
PATH
| Q1 26 | $309.9M | — | ||
| Q4 25 | $314.0M | $411.1M | ||
| Q3 25 | $310.6M | $361.7M | ||
| Q2 25 | $290.6M | $356.6M | ||
| Q1 25 | $269.7M | $423.6M | ||
| Q4 24 | $306.9M | $354.7M | ||
| Q3 24 | $282.4M | $316.3M | ||
| Q2 24 | $276.8M | $335.1M |
净利润
OMCL
PATH
| Q1 26 | $11.4M | — | ||
| Q4 25 | — | $198.8M | ||
| Q3 25 | $5.5M | $1.6M | ||
| Q2 25 | $5.6M | $-22.6M | ||
| Q1 25 | $-7.0M | $51.8M | ||
| Q4 24 | — | $-10.7M | ||
| Q3 24 | $8.6M | $-86.1M | ||
| Q2 24 | $3.7M | $-28.7M |
毛利率
OMCL
PATH
| Q1 26 | 45.3% | — | ||
| Q4 25 | 41.5% | 83.3% | ||
| Q3 25 | 43.3% | 82.2% | ||
| Q2 25 | 43.9% | 82.1% | ||
| Q1 25 | 41.1% | 84.8% | ||
| Q4 24 | 46.2% | 82.0% | ||
| Q3 24 | 43.3% | 80.0% | ||
| Q2 24 | 41.3% | 83.5% |
营业利润率
OMCL
PATH
| Q1 26 | 60.1% | — | ||
| Q4 25 | 0.1% | 3.2% | ||
| Q3 25 | 2.7% | -5.6% | ||
| Q2 25 | 2.8% | -4.6% | ||
| Q1 25 | -4.3% | 7.9% | ||
| Q4 24 | 4.0% | -12.2% | ||
| Q3 24 | 2.3% | -32.7% | ||
| Q2 24 | 1.2% | -14.8% |
净利率
OMCL
PATH
| Q1 26 | 3.7% | — | ||
| Q4 25 | — | 48.4% | ||
| Q3 25 | 1.8% | 0.4% | ||
| Q2 25 | 1.9% | -6.3% | ||
| Q1 25 | -2.6% | 12.2% | ||
| Q4 24 | — | -3.0% | ||
| Q3 24 | 3.1% | -27.2% | ||
| Q2 24 | 1.3% | -8.6% |
每股收益(稀释后)
OMCL
PATH
| Q1 26 | $0.25 | — | ||
| Q4 25 | $-0.05 | $0.37 | ||
| Q3 25 | $0.12 | $0.00 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $-0.15 | $0.09 | ||
| Q4 24 | $0.34 | $-0.02 | ||
| Q3 24 | $0.19 | $-0.15 | ||
| Q2 24 | $0.08 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $239.2M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $1.9B |
| 总资产 | $2.0B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
OMCL
PATH
| Q1 26 | $239.2M | — | ||
| Q4 25 | $196.5M | $1.4B | ||
| Q3 25 | $180.1M | $1.4B | ||
| Q2 25 | $399.0M | $1.6B | ||
| Q1 25 | $386.8M | $1.6B | ||
| Q4 24 | $369.2M | $1.6B | ||
| Q3 24 | $570.6M | $1.7B | ||
| Q2 24 | $556.8M | $1.9B |
股东权益
OMCL
PATH
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.2B | $1.9B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.2B | $1.8B | ||
| Q2 24 | $1.2B | $2.0B |
总资产
OMCL
PATH
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.9B | ||
| Q3 25 | $1.9B | $2.6B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.2B | $2.9B | ||
| Q4 24 | $2.1B | $2.7B | ||
| Q3 24 | $2.3B | $2.7B | ||
| Q2 24 | $2.3B | $2.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $54.5M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $38.6M | $25.1M |
| 自由现金流率自由现金流/营收 | 12.5% | 6.1% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | 4.80× | 0.14× |
| 过去12个月自由现金流最近4个季度 | $110.8M | — |
8季度趋势,按日历期对齐
经营现金流
OMCL
PATH
| Q1 26 | $54.5M | — | ||
| Q4 25 | $30.4M | $28.3M | ||
| Q3 25 | $28.3M | $41.6M | ||
| Q2 25 | $42.8M | $119.0M | ||
| Q1 25 | $25.9M | $146.1M | ||
| Q4 24 | $56.3M | $28.1M | ||
| Q3 24 | $22.8M | $46.4M | ||
| Q2 24 | $58.7M | $100.0M |
自由现金流
OMCL
PATH
| Q1 26 | $38.6M | — | ||
| Q4 25 | $22.6M | $25.1M | ||
| Q3 25 | $18.5M | — | ||
| Q2 25 | $31.0M | $106.2M | ||
| Q1 25 | $14.8M | $138.7M | ||
| Q4 24 | $47.2M | $23.2M | ||
| Q3 24 | $13.9M | $45.0M | ||
| Q2 24 | $49.1M | $98.8M |
自由现金流率
OMCL
PATH
| Q1 26 | 12.5% | — | ||
| Q4 25 | 7.2% | 6.1% | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 10.7% | 29.8% | ||
| Q1 25 | 5.5% | 32.7% | ||
| Q4 24 | 15.4% | 6.5% | ||
| Q3 24 | 4.9% | 14.2% | ||
| Q2 24 | 17.8% | 29.5% |
资本支出强度
OMCL
PATH
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | 0.8% | ||
| Q3 25 | 3.1% | 0.0% | ||
| Q2 25 | 4.1% | 3.6% | ||
| Q1 25 | 4.1% | 1.7% | ||
| Q4 24 | 3.0% | 1.4% | ||
| Q3 24 | 3.1% | 0.4% | ||
| Q2 24 | 3.5% | 0.4% |
现金转化率
OMCL
PATH
| Q1 26 | 4.80× | — | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | 5.18× | 26.25× | ||
| Q2 25 | 7.58× | — | ||
| Q1 25 | — | 2.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.64× | — | ||
| Q2 24 | 15.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OMCL
| Product revenues | $174.8M | 56% |
| Service revenues | $135.1M | 44% |
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |